Nasdaq

Mosaic ImmunoEngineering Inc. Announces Upgrade to OTCQB Venture Market and Upcoming Presentation at the B. Riley Oncology Investor Conference

NOVATO, CA / ACCESSWIRE / January 19, 2021 / Mosaic ImmunoEngineering Inc., (the "Company" or "Mosaic") (OTC PINK:CPMV), a development-stage biotechnology company focused on bridging immunology and ...
Nasdaq

Mosaic ImmunoEngineering Expands Immuno-Oncology Platform Through New Technology Licensing Agreement with the University of California San Diego

NOVATO, CA / ACCESSWIRE / October 6, 2021 / Mosaic ImmunoEngineering, Inc. ("Mosaic" or the "Company"), (OTCQB:CPMV), a development-stage biotechnology company focused on bridging immunology and ...